Titre :
  • Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer.
Auteur : Di Leo, Angelo ; Bleiberg, Harry ; Buyse, Marc
Informations sur la publication : Journal of clinical oncology, 21, 10, (page 2045-2047)
Statut de publication : Publié, 2003-05
Sujet CREF : Cancérologie
Mots-clés MeSH : Breast Neoplasms -- drug therapy -- mortality -- pathology
Clinical Trials, Phase III as Topic
Colorectal Neoplasms -- drug therapy -- mortality -- pathology
Confounding Factors (Epidemiology)
Humans
Neoplasm Metastasis
Survival Analysis
Treatment Outcome
Note : Letter
SCOPUS: le.j
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:doi/10.1200/JCO.2003.99.089
info:pii/JCO.2003.99.089
info:pmid/12743164